Matthew Hill, Founder and CEO of Elegen joins guest panel at SynbioBeta 2023 to discuss advances needed to unlock DNA synthesis.

Evolution of DNA Supply, What Advances in DNA Synthesis will Unlock the Agile Development of Biology.

Chris Ghadban, Principal of Alix Ventures, moderates a panel of guests including Matthew Hill, Founder and CEO of Elegen, Jacob Becraft, Co-Founder and CEO of Strand Therapeutics, Tim Lu, Co-founder and CEO of Senti Bio, Cristina Butterfield, Sr. Director of Biochemistry at Metagenomi, and Patrick Boyle, Organism Designer at Ginkgo Bioworks, to discuss how a better solution for DNA synthesis will enable synthetic biologists to realize the promise of programmable biology.